Compare ADMA Biologics Inc (ADMA) vs SpaceX (SPCX) Price & Performance

ADMA Biologics IncTrade

SpaceXTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs SpaceX — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while SpaceX trades at $134.85 (market cap $1.76T). The key difference: SpaceX is far larger — about 792.8× ADMA Biologics Inc's market cap, and SpaceX is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ADMA	SPCX
Market Cap	$2.22B	$1.76T
Sector	Health	Technology
52-Week High	$20.38	$202.09
52-Week Low	$7.60	$108.27
Enterprise Value	$2.29B	$1.70T

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ADMA

View details →

SPCX

SpaceX's AI revenue soars 247% YoY, set to dominate by Q3 with $300B potential by 2027Seeking Alpha · 4 hours agoBullish Investor Ron Baron predicts SpaceX could reach a $40 trillion valuation in 15 years, echoing his successful Tesla bet.24/7 Wall Street · 5 hours agoBullish Morgan Stanley values SpaceX's AI software Cursor at $33B ARR by 2030, boosting SpaceX's stock outlook.24/7 Wall Street · 5 hours agoBullish View details →

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.